| The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic … H Ghebeh, S Mohammed, A Al-Omair, A Qattant, C Lehe, G Al-Qudaihi, ... Neoplasia 8 (3), 190-198, 2006 | 725 | 2006 |
| FOXP3+ Tregs and B7-H1+/PD-1+T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy H Ghebeh, E Barhoush, A Tulbah, N Elkum, T Al-Tweigeri, S Dermime BMC cancer 8, 1-12, 2008 | 286 | 2008 |
| Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule H Ghebeh, C Lehe, E Barhoush, K Al-Romaih, A Tulbah, M Al-Alwan, ... Breast Cancer Research 12, 1-12, 2010 | 262 | 2010 |
| Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: significance in claudin-low breast cancer cells A Alsuliman, D Colak, O Al-Harazi, H Fitwi, A Tulbah, T Al-Tweigeri, ... Molecular cancer 14, 1-13, 2015 | 251 | 2015 |
| PD‐L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation S Almozyan, D Colak, F Mansour, A Alaiya, O Al‐Harazi, A Qattan, ... International journal of cancer 141 (7), 1402-1412, 2017 | 211 | 2017 |
| Expression of B7‐H1 in breast cancer patients is strongly associated with high proliferative Ki‐67‐expressing tumor cells H Ghebeh, A Tulbah, S Mohammed, N ElKum, SMB Amer, T Al‐Tweigeri, ... International journal of cancer 121 (4), 751-758, 2007 | 199* | 2007 |
| Microvascular injury, thrombosis, inflammation, and apoptosis in the pathogenesis of heatstroke: a study in baboon model GT Roberts, H Ghebeh, MA Chishti, F Al-Mohanna, R El-Sayed, ... Arteriosclerosis, thrombosis, and vascular biology 28 (6), 1130-1136, 2008 | 198 | 2008 |
| Breast carcinoma–associated fibroblasts and their counterparts display neoplastic-specific changes NM Hawsawi, H Ghebeh, SF Hendrayani, A Tulbah, M Al-Eid, ... Cancer research 68 (8), 2717-2725, 2008 | 167 | 2008 |
| Fascin is a key regulator of breast cancer invasion that acts via the modification of metastasis-associated molecules M Al-Alwan, S Olabi, H Ghebeh, E Barhoush, A Tulbah, T Al-Tweigeri, ... PloS one 6 (11), e27339, 2011 | 121 | 2011 |
| Pluronic enhances the robustness and reduces the cell attachment of mammalian cells T Tharmalingam, H Ghebeh, T Wuerz, M Butler Molecular biotechnology 39, 167-177, 2008 | 121 | 2008 |
| Fascin is involved in the chemotherapeutic resistance of breast cancer cells predominantly via the PI3K/Akt pathway H Ghebeh, S Al-Khaldi, S Olabi, A Al-Dhfyan, F Al-Mohanna, R Barnawi, ... British journal of cancer 111 (8), 1552-1561, 2014 | 86 | 2014 |
| Profiling of normal and malignant breast tissue show CD44high/CD24lowphenotype as a predominant stem/progenitor marker when used in combination with Ep … H Ghebeh, GM Sleiman, PS Manogaran, A Al-Mazrou, E Barhoush, ... BMC cancer 13, 1-14, 2013 | 86 | 2013 |
| Fascin is critical for the maintenance of breast cancer stem cell pool predominantly via the activation of the notch self-renewal pathway R Barnawi, S Al-Khaldi, G Majed Sleiman, A Sarkar, A Al-Dhfyan, ... Stem cells 34 (12), 2799-2813, 2016 | 73 | 2016 |
| Novel CARMIL2 mutations in patients with variable clinical dermatitis, infections, and combined immunodeficiency AM Alazami, M Al-Helale, S Alhissi, B Al-Saud, H Alajlan, D Monies, ... Frontiers in Immunology 9, 203, 2018 | 68 | 2018 |
| PD-L1 is overexpressed on breast cancer stem cells through notch3/mTOR axis FA Mansour, A Al-Mazrou, F Al-Mohanna, M Al-Alwan, H Ghebeh Oncoimmunology 9 (1), 1729299, 2020 | 65 | 2020 |
| Therapeutic targeting of B7-H1 in breast cancer A Hasan, H Ghebeh, C Lehe, R Ahmad, S Dermime Expert opinion on therapeutic targets 15 (10), 1211-1225, 2011 | 60 | 2011 |
| The Wilms' tumor antigen is a novel target for human CD4+ regulatory T cells: implications for immunotherapy C Lehe, H Ghebeh, A Al-Sulaiman, G Al Qudaihi, K Al-Hussein, ... Cancer research 68 (15), 6350-6359, 2008 | 60 | 2008 |
| Differential marker expression by cultures rich in mesenchymal stem cells A Wetzig, A Alaiya, M Al-Alwan, CB Pradez, MS Pulicat, A Al-Mazrou, ... BMC cell biology 14, 1-12, 2013 | 52 | 2013 |
| Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triple‐negative breast cancer NN Alraouji, FH Al‐Mohanna, H Ghebeh, M Arafah, R Almeer, ... Molecular Carcinogenesis, 2020 | 50 | 2020 |
| β1 integrin is essential for fascin‐mediated breast cancer stem cell function and disease progression R Barnawi, S Al‐Khaldi, D Colak, A Tulbah, T Al‐Tweigeri, M Fallatah, ... International Journal of Cancer 145 (3), 830-841, 2019 | 48 | 2019 |
Prof. Said Dermime MSc; PhDSenior Scientist & Director of Translational Cancer Research Facility, NCCCR, Qatar在 hamad.qa 的电子邮件经过验证
